Medigen presents vaccine research at ASV 2024

ppushko2024-07-13T22:22:27+00:00July 13th, 2024|

VACCINE COMPANY MEDIGEN DOUBLES PRESENCE IN RIVERSIDE TECHNOLOGY PARK TO 12,000 SQUARE FEET OF SPACE WITH PLANS TO INCREASE VACCINE MANUFACTURING

Accelerant2023-01-04T18:15:47+00:00September 2nd, 2022|

Company engaged in contract manufacturing and developing vaccines against infectious diseases expanding at Gas House Pike to support additional office, research and manufacturing space

[…]

Medigen reports vaccines for Venezuelan Equine Encephalitis and Chikungunya viruses

ppushko2019-02-14T05:03:15+00:00January 29th, 2019|

January 29, 2019. Medigen presented experimental vaccines for two life-threatening emerging viruses at the 2019 ASM Biothreats conference in Washington, DC. Venezuelan […]